Use and limitations of imatinib mesylate (Glivec), a selective inhibitor of the tyrosine kinase Abl transcript in the treatment of chronic myeloid leukaemia (Q35834634)
Jump to navigation
Jump to search
scientific article published in January 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Use and limitations of imatinib mesylate (Glivec), a selective inhibitor of the tyrosine kinase Abl transcript in the treatment of chronic myeloid leukaemia |
scientific article published in January 2004 |
Statements
1 reference
Use and limitations of imatinib mesylate (Glivec), a selective inhibitor of the tyrosine kinase Abl transcript in the treatment of chronic myeloid leukaemia (English)
1 reference
Knight GW
1 reference
McLellan D
1 reference
1 January 2004
1 reference
1 reference
61
1 reference
2
1 reference
103-111
1 reference
Identifiers
1 reference
1 reference